rs371061770
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_000256.3(MYBPC3):c.3137C>T(p.Thr1046Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00014 in 1,604,248 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYBPC3 | NM_000256.3 | c.3137C>T | p.Thr1046Met | missense_variant | 29/35 | ENST00000545968.6 | NP_000247.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.3137C>T | p.Thr1046Met | missense_variant | 29/35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.3137C>T | p.Thr1046Met | missense_variant | 28/34 | 5 | ENSP00000382193.2 |
Frequencies
GnomAD3 genomes AF: 0.0000722 AC: 11AN: 152256Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000660 AC: 16AN: 242472Hom.: 0 AF XY: 0.0000529 AC XY: 7AN XY: 132218
GnomAD4 exome AF: 0.000147 AC: 214AN: 1451874Hom.: 1 Cov.: 33 AF XY: 0.000144 AC XY: 104AN XY: 722728
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152374Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74502
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Jan 11, 2024 | This missense variant replaces threonine with methionine at codon 1046 of the MYBPC3 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been performed for this variant. This variant has been reported in Japanese individuals affected with hypertrophic cardiomyopathy (PMID: 18929575, 22560514) and in a Japanese individual with abnormal findings in electrocardiography (PMID: 26178432). This variant has also been identified in 16/242472 chromosomes (12/17958 East Asian chromosomes) in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
Primary familial hypertrophic cardiomyopathy Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | CSER _CC_NCGL, University of Washington | Jun 01, 2014 | - - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Feb 17, 2023 | This missense variant replaces threonine with methionine at codon 1046 of the MYBPC3 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with hypertrophic cardiomyopathy (PMID: 18929575, 22560514, 32841044, 33495596) and in an individual with abnormal findings in electrocardiography (PMID: 26178432). This variant has been identified in 16/242472 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 03, 2023 | Identified in patients with HCM, abnormal ECG findings, and/or sudden death (PMID: 17560888, 18929575, 22560514, 33658040, 29398688); several patients harbored additional cardiogenetic variants; A published functional study suggests the p.(T1046M) variant results in similar protein levels compared to wildtype (PMID: 18929575); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 24510615, 14638934, 17560888, 22560514, 23299917, 26178432, 21415409, 25637381, 33561224, 33658040, 18929575, 30959811, 29398688) - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 16, 2014 | p.Thr1046Met variant in exon 29 of MYBPC3: This variant is not expected to have clinical significance because the threonine (Thr) at position 1046 is not conser ved in mammals or evolutionarily distant species. Of note, 5 mammals (macaque, cat, dog, panda, and cape golden mole) have a methionine (Met) at this position despite high nearby amino acid conservation. Moreover, this variant was predicte d to be benign using a computational tool clinically validated by our laboratory . This tool's benign prediction is estimated to be correct 89% of the time (Jord an 2011). - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at